- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatments in Alzheimer’s disease ; volume:264 ; number:2 ; day:24 ; month:1 ; year:2017 ; pages:416-418 ; date:2.2017
Journal of neurology ; 264, Heft 2 (24.1.2017), 416-418, 2.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Malik, G. A.
- Beteiligte Personen und Organisationen
-
Robertson, N. P.
SpringerLink (Online service)
- DOI
-
10.1007/s00415-017-8395-1
- URN
-
urn:nbn:de:1111-20170228101
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Malik, G. A.
- Robertson, N. P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease